Journal articleCancer Discov2020
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.
- Journal
- Cancer Discov
- Published
- 11 February 2020
- Citations
- 198
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 8
- Targeting malic enzyme 3 as a synthetic lethality target in pancreatic cancer K99CA218891↗
- Core C-Computational Core P01CA117969↗
- Administrative Core P50CA221707↗
- Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer R00CA218891↗
- Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism R01CA204969↗
- Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer R01CA218004↗
- Exploring Collateral Lethality for Development of Cancer Therapeutics R01CA225955↗
- Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC) U24CA224020↗